"Scepticism About Sputnik V Gone": Russian Direct Investment Fund CEO

"The scepticism about Sputnik V is gone after Lancet's report on its efficacy," says Kirill Dmitriev, CEO of Russian Direct Investment Fund, on partnership with India-based drug-mark for the production of 200 million doses of the vaccine.

Related Videos